22 November 2018 -
The
global Herbal Medicine Market is expected to reach USD
117.02 billion by 2024, driven by rising popularity of herbal therapeutics
compared to conventional drugs. The market for herbal medicines and remedies is
anticipated to record profitable growth due to their cost-effectiveness as
compared to allopathic ones.
In 2016,
Europe was the largest market for traditional medicines, contributing to 40.8%
of the share and is expected to retain its leadership during the forecast
period due to shifting from conventional drugs to herbal products. Fewer side
effects and low toxicity compared to allopathy products are expected to provide
a competitive advantage over other medicines in the market. Additionally, ready
acceptance of herbal products owing to its benefits is the key factor for
market growth and is expected to play a significant role in future.
Increased
preference of complementary and alternative medicine (CAM) among others has
resulted in the growth of herbal medicines in Asia Pacific. Asia Pacific is
expected to record the fastest CAGR of 6.8% over the forecast period.
Furthermore, Europe is anticipated to generate maximum revenue over the
forecast period due to increasing awareness created by various associations
such as Association for Natural Medicine in Europe (AIME).
Browse
Details of Report @ https://www.hexaresearch.com/research-report/global-herbal-medicine-market
Concerning
product segment, tablets & capsules are expected to witness the fastest
growth owing to increasing acceptance of tablets over extracts and powders.
Furthermore, properties such as high dose accuracy essential for optimum
therapeutic effect will, in turn, promote the herbalism market growth. The
extracts segment is expected to grow at a lucrative rate as they show an
immediate therapeutic effect on administration.
For
instance, in geriatric patients, extracts and other liquid dosage forms are
preferred for administration as tablets show delayed therapeutic effect.
Furthermore, extracts provide high potency as they possess only the active
ingredients and no fillers which are present in tablets & capsules.
The
rigorous focus on developing better extraction and purification techniques by
herbal medicine manufacturers is expected to fuel the market. Furthermore,
respective governments are also introducing several strategies to promote the
uptake of herbal medicine market. For instance, in July 2017, the Chinese
Ministry of Science and Technology invested USD 12.5 million for development of
herbal treatments for the treatment of cancer and HIV/AIDS.
Hexa
Research has segmented the global herbal medicine market based on Product,
Indication, and region:
Segmentation
by Product, 2014 - 2024 (USD Billion)
• Tablets & Capsules
• Powders
• Extracts
• Others
• Tablets & Capsules
• Powders
• Extracts
• Others
Segmentation
by Indication, 2014 - 2024 (USD Billion)
• Digestive Disorders
• Respiratory Disorders
• Blood Disorders
• Others
• Digestive Disorders
• Respiratory Disorders
• Blood Disorders
• Others
Segmentation
by Region, 2014 - 2024 (USD Billion)
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Central & South America
• Middle East and Africa
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Central & South America
• Middle East and Africa
Key Players
Analyzed
• TSUMURA & CO.
• Dr. Willmar Schwabe India Pvt. Ltd.
• Blackmores
• NATURE'S ANSWER
• Arkopharma
• Arizona Natural Products
• Herbal Africa
• Bio Botanica, Inc.
• Sidomuncul
• Nature Herbs
• TSUMURA & CO.
• Dr. Willmar Schwabe India Pvt. Ltd.
• Blackmores
• NATURE'S ANSWER
• Arkopharma
• Arizona Natural Products
• Herbal Africa
• Bio Botanica, Inc.
• Sidomuncul
• Nature Herbs
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry
About Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website: https://www.hexaresearch.com
No comments:
Post a Comment